Putative Mechanisms Underlying Cardiovascular Disease Associated with Clonal Hematopoiesis of Indeterminate Potential

Sarah S Burns1, Reuben Kapur2

  • 1Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA; Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Stem Cell Reports
|August 1, 2020
PubMed

Insights

Clonal hematopoiesis of indeterminate potential (CHIP) mutations in aging individuals increase risks for hematological cancers and cardiovascular disease (CVD). This review explores how CHIP impacts stem cells and various blood cell types to influence these diseases.

Area of Science:

  • Hematology
  • Genetics
  • Cardiovascular Science

Background:

  • Clonal hematopoiesis of indeterminate potential (CHIP) involves somatic mutations in aging individuals.
  • CHIP increases the risk of hematological malignancies and cardiovascular disease (CVD).
  • Mutations in hematopoietic stem and progenitor cells (HSPCs) may affect diverse blood lineages involved in CVD pathogenesis.

Purpose of the Study:

  • To review mechanisms linking CHIP-associated mutations to CVD.
  • To explore potential pathogenic links between CHIP-associated CVD and hematological malignancy.
  • To highlight the role of stem cell biology in CHIP-related diseases.

Main Methods:

  • This is a review article, synthesizing existing research.
  • Discussion of proposed pathogenic mechanisms.
  • Analysis of stem cell biology's role.

Main Results:

  • CHIP mutations can affect multiple hematopoietic lineages.
  • Inflammation is a potential mechanism linking CHIP, CVD, and hematological malignancy.
  • The relationship between CHIP-associated CVD and hematological malignancy suggests a common disease spectrum.

Conclusions:

  • CHIP mutations contribute to both CVD and hematological malignancy.
  • Understanding stem cell alterations is crucial for CHIP-related disease pathogenesis and treatment.
  • Further research is needed to elucidate the common pathways linking CHIP to CVD and hematological malignancy.

Related Concept Videos

Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.7K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.7K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
3.9K
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
3.4K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
7.8K